Electronic Journal of General Medicine

• Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol 2011; 35 (3): 175–84.
• Ip S, Chung M, Kulig J, et al. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004;114(1): e130–53.
• American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1): 297–316.
• Robitaille N, Nuyt AM, Panagopoulos A, Hume HA. Exchange Transfusion in the Infant In: CD Hillyer, RG Strauss, Luban NLC, editors. Handbook of pediatric transfusion medicine, first ed. Elsevier, Philadelphia 2004: 159–65.
• Tıraş Ü, Yılmaz R, Dallar Y. Neonatal Exchange Transfusion: Experience of a State Hospital in Ankara During a Four Year Period. ADU Medical Faculty J 2008; 9 (2): 5–10. (Turkish)
• Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr 2009; 5 (1): 51–5.
• Bolat F, Uslu S, Bülbül A, Cömert S, Can E, Nuhoğlu A. Evalution of term newborns hospitalized in our NICU with the diagnosis of indirect hyperbilirubinemia. Pediatrics J 2010; 10 (2): 69–74.(Turkish)
• Özkaya H, Karademir F, Süleymanoğlu S, et al. Anti-E antibody related hemolytic disease of newborn: Case report. Nobel Med 2006; 2(1):24-6.
• Aslan Y, Erduran E, Gedik Y, Mocan H, Yıldıran A, Soylu H. Kell C and E subgroup incompatibilities in neonates with indirect hyperbilirubinemia. Turkey Clin J Pediatr 1996; 5 (3): 93–8.
• Can E, Özkaya H, Meral C, et al. Anti-C hemolytic disease of the newborn and prolonged jaundice: report of three cases. Pediatrisc Dis Health J 2009; 52: 88–90.
• Hosseinpour Sakha S, Gharehbaghi MM. Exchange transfusion in severe hyperbilirubinemia: an experience in northwest Iran. Turk J Pediatr 2010; 52 (4): 367–71.
• Davutoğlu M, Garipardiç M, Güler E, Karabiber H, Erhan D. The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion. Turk J Pediatr 2010; 52 (2): 163–6.
• Tønne A, Meberg A, Hager HB. Trends in the diagnosis and management of neonatal hyperbilirubinaemia. Tidsskr Nor Laegeforen 2010; 130 (1): 18–20.
• Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. J Pediatr 2007; 150 (4): 412–7.
• Mishra S, Agarwal R, Deorari AK, Paul VK. Jaundice in the newborns. Indian J Pediatr 2008; 75 (2): 157–63.
• Bhutani VK, Johnson LH, Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am 2004; 51 (4): 843–61.
• Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007; 120 (1): 27–32.
• Badiee Z. Exchange transfusion in neonatal hyperbilirubinemia: experience in Isfahan, Iran. Singapore Med J 2007; 48 (5): 421–3.
• Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Can Med Assoc J 2006; 175: 587–90.
• Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and nearterm newborns. Pediatrics 1999; 103: 6–14.
• Zipursky A, Bowman JM. Isoimmune hemolytic diseases. In: Nathan DG, Oski FA (eds). Hematology of Infancy and Childhood (6th ed) Vol 1. Philadelphia: WB Saunders, 2003: 44–73.
• Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997; 89: 272–5.
• Van Dijk BA, Hirasing RA, Overbeeke MA. Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity. Ned Tijdschr Geneeskd 1999; 143: 1465–9.
• Wagner T, Resch B, Legler TJ, et al. Severe HDN due to anti-Ce that required exchange transfusion. Transfusion 2000; 40: 571–4.
• Bowman JM, Pollock JM, Manning FA, et al. Severe anti-C hemolytic disease of the newborn. Am J Obstet Gynecol 1992; 166: 1239–43.
• Hammerman C, Kaplan M. Recent developments in the management of neonatal hyperbilirubinemia. Neo Reviews 2000; 1: e19-e24.
• Kubo S, Ariga T, Tsuneta H, Ishii T. Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis? A successful case of haemolytic disease due to rhesus (c + E) incompatibility. Eur J Pediatr 1991; 150 (7): 507–8.

Vancouver

Annagür A, Altunhan H, Konak M, Koç H, Örs R. Role of Subgroup Incompatibility in Newborn Jaundice Requiring Exchange Transfusion. EUR J GEN MED. 2014;11(2):66-70. https://doi.org/10.15197/sabad.1.11.41

APA

Annagür, A., Altunhan, H., Konak, M., Koç, H., & Örs, R. (2014). Role of Subgroup Incompatibility in Newborn Jaundice Requiring Exchange Transfusion. European Journal of General Medicine, 11(2), 66-70. https://doi.org/10.15197/sabad.1.11.41

AMA

Annagür A, Altunhan H, Konak M, Koç H, Örs R. Role of Subgroup Incompatibility in Newborn Jaundice Requiring Exchange Transfusion. EUR J GEN MED. 2014;11(2), 66-70. https://doi.org/10.15197/sabad.1.11.41

Chicago

Annagür, Ali, Hüseyin Altunhan, Murat Konak, Hasan Koç, and Rahmi Örs. "Role of Subgroup Incompatibility in Newborn Jaundice Requiring Exchange Transfusion". European Journal of General Medicine 2014 11 no. 2 (2014): 66-70. https://doi.org/10.15197/sabad.1.11.41

Harvard

Annagür, A., Altunhan, H., Konak, M., Koç, H., and Örs, R. (2014). Role of Subgroup Incompatibility in Newborn Jaundice Requiring Exchange Transfusion. European Journal of General Medicine, 11(2), pp. 66-70. https://doi.org/10.15197/sabad.1.11.41

MLA

Annagür, Ali et al. "Role of Subgroup Incompatibility in Newborn Jaundice Requiring Exchange Transfusion". European Journal of General Medicine, vol. 11, no. 2, 2014, pp. 66-70. https://doi.org/10.15197/sabad.1.11.41